There have been some significant developments in the bisphosphonate litigation over the past few months. Now that the two-year anniversary of the FDA’s safety alert over atypical femur fractures has passed, we anticipate that nearly 70 to 80% of the bisphosphonate cases in the country have now been filed. The […]
Author: Brenda Fulmer
I was thrilled to hear that some of our elected members of Congress are finally working on proactive legislation that might benefit all of us. This is especially encouraging after watching with much discouragement the high level of discord and dysfunction that has become commonplace in the Capitol. Recently, some […]
The Judicial Panel on Multi-District Litigation issued an order on April 17, 2012, establishing MDL No. 2342 styled In Re: Zoloft (setraline hydrochloride) Products Liability Litigation. This order will establish coordinated multi-district proceedings in the federal court in the Eastern District of Pennsylvania for lawsuits that have been filed on […]
Bloomberg is reporting today that Bayer has now settled approximately 500 of the more than 10,000 lawsuits pending against the German drug manufacturer. The reports indicate that the cases were confidentially settled for the sum of $110 million, or slightly more than an average of $200,000 per case. Settlement negotiations […]
This is the typical refrain from so many of our clients who were implanted with defective metal-on-metal hip implants made by orthopedic giants like DePuy, Stryker, Wright Medical, and Zimmer. The irony is that those who utter those words are actually very close to the emerging stereotype for these clients. […]
A newly published study finds that first-time users of a class of drugs to treat osteoporosis may be at an increased risk of serious inflammatory eye disease. Bisphosphonates such as Fosamax and Actonel, which are taken orally, are two of the most commonly prescribed drugs in that class. Published in […]
Better late than never? The U.S. Food and Drug Administration (FDA) will hold a gathering of scientific and clinical experts to discuss whether metal-on-metal (MoM) artificial hip systems should undergo more rigorous scientific scrutiny before they are implanted in U.S. patients, which sounds infinitely reasonable. On Thursday, March 29, the […]
The U.S. Food and Drug Administration (FDA) has revised its recommendations for the popular antidepressant, Celexa (citalopram hydrobromide). Last August, the FDA warned Celexa should be limited to doses no greater than 40 mg per day because of a risk of abnormal electrical activity in the heart known as Torsade […]
It’s little known and rarely applied but the Park doctrine does allow the U.S. government to file a misdemeanor criminal charge against corporate officials even if they didn’t intend to violate any law. The law is based on the conviction of a Mr. John Park, who owned Acme Markets, a […]
On March 26, 2012, Searcy Denney filed two additional individual lawsuits against Bayer Corporation, the manufacturer of Yasmin and Yaz. One of the new cases was filed on behalf of a married Texas woman who works as a Head Start teacher. She started taking Yasmin in 2008, and quickly developed […]
